0558/2016 - Contemporary challenges on Access to Medicines: beyond the UNSG High-Level Panel Contemporary challenges on Access to Medicines: beyond the UNSG High-Level Panel
• Claudia Patricia Vaca Gonzalez - Vaca Gonzalez, Claudia Patricia - Universidad Nacional de Colombia - <cpvacag@unal.edu.co>
• Carolina Gomez - Gomez, Carolina - Universidad Nacional de Colombia - <carolinagom@gmail.com>
Área Temática:
Não Categorizado
Resumo:
Within the context of the recently released United Nations Secretary-General´s Report of the High-Level Panel on Access to Medicines, the author reviews issues related to the context and discussions on access to medicines and the conflict between trade and health during the last decades. These issues have been relevant and outstanding in Global Health, especially questioning the current system of innovation, R&D and IP protection. Lessons learnedthe HLP Report are highlighted and the need to further discuss and implement concrete actions, as the world has movedthe MDGs to the SDGs, demand strong actions derivedthe United Nations and a strong interaction with other key stakeholders. Affordability and unaffordability of new technologies are discussed, making clear that we need to implement bold actions in order to ensure access to medicines as a human right.
Palavras-chave:
Health policiesAccess to medicineGlobal Health
Abstract:
Within the context of the recently released United Nations Secretary-General´s Report of the High-Level Panel on Access to Medicines, the author reviews issues related to the context and discussions on access to medicines and the conflict between trade and health during the last decades. These issues have been relevant and outstanding in Global Health, especially questioning the current system of innovation, R&D and IP protection. Lessons learnedthe HLP Report are highlighted and the need to further discuss and implement concrete actions, as the world has movedthe MDGs to the SDGs, demand strong actions derivedthe United Nations and a strong interaction with other key stakeholders. Affordability and unaffordability of new technologies are discussed, making clear that we need to implement bold actions in order to ensure access to medicines as a human right.
Contemporary challenges on Access to Medicines: beyond the UNSG High-Level Panel
Resumo (abstract):
Within the context of the recently released United Nations Secretary-General´s Report of the High-Level Panel on Access to Medicines, the author reviews issues related to the context and discussions on access to medicines and the conflict between trade and health during the last decades. These issues have been relevant and outstanding in Global Health, especially questioning the current system of innovation, R&D and IP protection. Lessons learnedthe HLP Report are highlighted and the need to further discuss and implement concrete actions, as the world has movedthe MDGs to the SDGs, demand strong actions derivedthe United Nations and a strong interaction with other key stakeholders. Affordability and unaffordability of new technologies are discussed, making clear that we need to implement bold actions in order to ensure access to medicines as a human right.
